CAPTRUST Financial Advisors
SGMO

CAPTRUST Financial Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.4K Buy
268,755
+239,500
+819% +$95.3K ﹤0.01% 2868
2025
Q4 		$12.3K Hold
29,255
– – ﹤0.01% 2728
2025
Q3 		$19.7K Hold
29,255
– – ﹤0.01% 2603
2025
Q2 		$15.8K Hold
29,255
– – ﹤0.01% 2478
2025
Q1 		$19.2K Hold
29,255
– – ﹤0.01% 2321
2024
Q4 		$29.8K Buy
+29,255
New +$53.5K ﹤0.01% 2263
2022
Q3 		– Sell
-1,238
Closed -$5K – 3705
2022
Q2 		$5K Sell
1,238
-693
-36% -$3K ﹤0.01% 4116
2022
Q1 		$11K Sell
1,931
-77
-4% -$458 ﹤0.01% 3753
2021
Q4 		$15K Buy
2,008
+239
+14% +$2.08K ﹤0.01% 3486
2021
Q3 		$16K Hold
1,769
– – ﹤0.01% 3320
2021
Q2 		$21K Sell
1,769
-3,131
-64% -$35.4K ﹤0.01% 3079
2021
Q1 		$61K Buy
4,900
+1,173
+31% +$15.8K ﹤0.01% 2301
2020
Q4 		$58K Sell
3,727
-1,252
-25% -$14.7K ﹤0.01% 1762
2020
Q3 		$47K Buy
4,979
+128
+3% +$1.38K ﹤0.01% 1658
2020
Q2 		$46K Buy
+4,851
New +$45K ﹤0.01% 1653

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

CAPTRUST Financial Advisors's SGMO Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 819% in Q1 2026, buying an estimated $95.3K and bringing the position to 268,755 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2868.

CAPTRUST Financial Advisors first reported a position in SGMO in Q2 2020 and has held it in 15 quarters since. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • CAPTRUST Financial Advisors held 268,755 shares of SANGAMO THERAPEUTICS INC worth $66.4K as of Q1 2026.
  • CAPTRUST Financial Advisors bought 239,500 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $95.3K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2868 holding.
  • CAPTRUST Financial Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and has held it in 15 quarters since.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.